531 related articles for article (PubMed ID: 23543195)
1. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?
Eom BW; Joo J; Kim YW; Park B; Park JY; Yoon HM; Lee JH; Ryu KW
Ann Surg Oncol; 2013 Aug; 20(8):2669-75. PubMed ID: 23543195
[TBL] [Abstract][Full Text] [Related]
2. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
[TBL] [Abstract][Full Text] [Related]
4. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
[TBL] [Abstract][Full Text] [Related]
6. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
7. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
9. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
10. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
11. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
13. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
[TBL] [Abstract][Full Text] [Related]
14. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R
Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy in patients with gastric cancer. A critical review.
Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
[TBL] [Abstract][Full Text] [Related]
16. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
17. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
[TBL] [Abstract][Full Text] [Related]
19. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
Putchakayala K; Difronzo LA
Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
[TBL] [Abstract][Full Text] [Related]
20. [The significance of No.13 lymph node dissection in D2 gastrectomy for lower-third advanced gastric cancer].
Jiao XG; Liang H; Deng JY; Wang L; Liu HG; Liang YX
Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):235-9. PubMed ID: 23859325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]